Global Theranostics Market Share, Current and Future Industry Trends 2028

According to the business intelligence report titled ‘Global Theranostics Market 2022-2028’, available with MarketStudyReport, global theranostics market is slated to grow at a CAGR of 9.6% through 2028 and reach a valuation of USD 123,694 million by the end of the analysis timeframe.

Increase in the prevalence of cancer and other chronic illnesses, in congruence with growing investments on biological research are the major factors propelling global theranostics market growth.

Request sample copy of this report:

https://www.marketstudyreport.com/request-a-sample/4973415/?utm_source=Marketwatch.com&utm_medium=SK

For the unversed, the term theranostics is the amalgamation of the words therapeutics and diagnostics. Its main course of action follows the utilization of one radioactive drug to diagnose, while the other is used to deliver therapy to treat main or other kinds of metastatic tumors. Theranostics is also referred to as Dx/Rx, companion diagnostics, pharmacodiagnostics, and integrated medicine.

Furthermore, surge in research & development, rapid approvals from the FDA for novel approaches, and growing awareness regarding the quality of the drugs are bound to uncover new opportunities for market expansion during the forecast period.

Despite the positive outlook, several flaws associated with a defined regulatory landscape, alongside lack of reimbursement policies in emerging economies may hamper the growth trajectory of the market in the ensuing years.

Apart from growth drivers and challenges, the research literature furnishes a comprehensive segmental assessment of worldwide theranostics industry that highlights historical and current trends with respect to product type, therapeutic area, and regional expanse.

Speaking of which, different product types are therapeutic agents, theranostic agents, imaging equipment, and companion diagnostics. While various diagnostic areas include respiratory, immunology & infectious diseases (RIIDs), neurological disorders, cardiovascular diseases (CVDs), oncology, and others.

Considering regional extent, the overall industry spans across Europe, Asia Pacific, and Europe. Consumption patterns prevalent in each regional market are entailed within the document so as to facilitate stakeholders to make well-informed decisions and expand their profitability.

Speaking of the competitive landscape, Johnson & Johnson, GlaxoSmithKline plc (GSK plc), Pfizer Inc., F. Hoffmann-La Roche AG, Theragnostics Ltd., Innate Pharma S.A., Bristol-Myers Squibb Company, Merck KGaA, Ipsen S.A., Innate Pharma S.A., Novartis International AG, Sanofi S.A., Progenics Pharmaceuticals Inc., and Theradiag S.A. are the prominent players influencing global theranostics market trends.

Questions and Answers: – Global theranostics market

Question 1. Which are the major factors propelling global theranostics market growth?

Answer 1. Increase in the prevalence of cancer and other chronic illnesses, in congruence with growing investments on biological research are the major factors propelling global theranostics market growth.

Question 2. How will global theranostics market perform during 2022-2028?

Answer 2. Global theranostics market is expected to record a compound annual growth rate of 9.6% through 2028 and attain a valuation of USD 123,694 million by the end of the analysis timeframe.

Question 3. Which are the prominent players influencing global theranostics market trends?

Answer 3. GlaxoSmithKline plc (GSK plc), Pfizer Inc., F. Hoffmann-La Roche AG, Theragnostics Ltd., Innate Pharma S.A., Bristol-Myers Squibb Company, Merck KGaA, Ipsen S.A., Innate Pharma S.A., Novartis International AG, Sanofi S.A., Progenics Pharmaceuticals Inc. and Theradiag S.A. are the prominent players influencing global theranostics market trends.

For more details on this report:

https://www.marketstudyreport.com/reports/global-theranostics-market-2022-2028/?utm_source=Marketwatch.com&utm_medium=SK

About Us:

Market Study Report is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report to ease their search and evaluation of market intelligence products and services and in turn focus on their company’s core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report. is the platform that can help you in achieving any of these objectives.

 

Contact Us:

Corporate Sales,

Market Study Report

Phone: 1-302-273-0910

Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Leave a Reply

Your email address will not be published.